MarketCapTrends
EXEL

Exelixis Inc. (EXEL)

NASDAQ · Healthcare

Exelixis Inc. annual/quarterly shareholder equity history from 2010 to 2026. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Exelixis Inc. shareholder equity for the quarter ending January 2, 2026 were 2.16B, a 3.69% decrease year-over-year.
  • Exelixis Inc. shareholder equity for 2026 were 2.16B, a 3.69% decrease from 2025.
  • Exelixis Inc. shareholder equity for 2025 were 2.24B, a 0.87% decrease from 2023.
  • Exelixis Inc. shareholder equity for 2023 were 2.26B, a 9.02% decrease from 2022.
  • Exelixis Inc. shareholder equity for 2022 were 2.49B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Exelixis Inc. Annual Shareholder Equity (Millions of US $)
2026$2,161
2025$2,244
2023$2,264
2022$2,488
2021$2,211
2020$1,686
2018$1,287
2017$285
2016$89
2015$-141
2014$-159
2013$14
2012$238
2011$91
2010$-228
Exelixis Inc. Quarterly Shareholder Equity (Millions of US $)
2026-01-02$2,161
2025-01-03$2,244
2023-12-29$2,264
2022-12-30$2,488
2021-12-31$2,211
2021-01-01$1,879
2020-01-03$1,686
2018-12-28$1,287
2017-12-29$285
2016-12-31$89
2016-12-30$89
2015-12-31$-141
2014-12-31$-159
2013-12-31$14
2012-12-31$238
2011-12-31$91
2010-12-31$-228

Exelixis Inc. Shareholder Equity — FAQ

Exelixis Inc. (EXEL) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see EXEL's shareholder equity history?

The chart and table above show Exelixis Inc.'s shareholder equity by year and by quarter, including the growth rate.